Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes

doi:10.4239/wjd.v15.i6.1263

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (308)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

HTML

198

Figures (1-1)

Tables (1-4)

Sum=278

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=10

Jun 15, 2024 (publication date) through Jun 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Jun 15, 2024; 15(6): 1263-1271
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1263

Table 1 Clinical characteristics of study participates by quartiles of hemoglobin A1c

Variables	HbA1c quartiles				P value
Variables	Q1 (< 7.875), n = 32	Q2 (7.875-9.050), n = 33	Q3 (9.050-11.200), n = 32	Q4 (≥ 11.200), n = 33	P value
Age (yr)	63.5 ± 13.3	60.9 ± 9.7	59.5 ± 16.1	60.2 ± 13.0	0.640
Sex (male/female)	18/14 (56.3/43.8)	16/17 (48.5/51.5)	20/12 (62.5/37.5)	21/12 (63.6/36.4)	0.582
Diabetes duration (yr)	6.5 (3.0, 17.5)	10 (6.5, 15.0)	8.0 (1.3, 19.8)	5.0 (1.0, 12.0)	0.173
Height (cm)	165.6 ± 8.1	164.2 ± 8.8	166.8 ± 9.0	167.4 ± 6.6	0.392
Weight (cm)	71.5 ± 11.5	70.9 ± 11.4	73.8 ± 18.3	71.4 ± 8.7	0.803
BMI (kg/m²)	26.1 ± 3.7	26.2 ± 3.3	26.2 ± 4.5	25.4 ± 2.5	0.772
Neck line (cm)	39.1 ± 3.5	38.2 ± 3.8	38.3 ± 4.0	38.4 ± 2.4	0.731
Waist line (cm)	97.3 ± 8.9	95.0 ± 10.2	94.5 ± 11.1	94.7 ± 8.5	0.646
Hip line (cm)	103.5 ± 8.3	102.1 ± 8.8	100.3 ± 9.7	100.9 ± 8.7	0.492
WHR	0.94 ± 0.05	0.93 ± 0.04	0.94 ± 0.05	0.94 ± 0.04	0.698
SBP (mmHg)	132.8 ± 21.2	139.1 ± 17.5	132.6 ± 20.3	134.3 ± 16.2	0.474
DBP (mmHg)	77.2 ± 9.0	80.0 ± 8.2	78.3 ± 9.0	80.3 ± 8.0	0.415
mALB (g/L)	11.0 (11.0, 41.5)	11.0 (10.5, 50.0)	32.5 (12.0, 123.5)	20.0 (12.5, 53.5)	0.031
TC (mmol/L)	4.46 ± 1.01	4.70 ± 1.11	4.81 ± 1.29	5.00 ± 1.35	0.321
TG (mmol/L)	1.54 (1.04, 2.32)	2.17 (1.10, 2.93)	1.81 (1.37, 3.83)	1.37 (0.84, 2.28)	0.044
HDL-C (mmol/L)	1.25 ± 0.37	1.11 ± 0.32	1.10 ± 0.31	1.14 ± 0.31	0.274
LDL-C (mmol/L)	2.83 ± 1.10	3.02 ± 1.02	2.89 ± 0.88	3.51 ± 1.15	0.037
HOMA-IR	3.09 (1.69, 4.48)	4.59 (3.07, 7.12)	6.05 (4.34, 10.41)	6.06 (3.62, 8.14)	< 0.001
HOMA-β	80.15 (35.79, 131.06)	38.55 (21.90, 73.18)	53.04 (22.48, 96.73)	21.70 (10.86, 45.92)	0.001
Complicated with hypertension (%)	17 (53.1)	21 (63.6)	17 (53.1)	18 (54.5)	0.796
Complicated with CHD (%)	20 (62.5)	18 (54.5)	23 (71.9)	18 (54.5)	0.429

HbA1c: Hemoglobin A1c; BMI: Body mass index; WHR: Waist-to-hip ratio; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; mALB: Microalbumin; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-β: Homeostasis model assessment of beta cell function; CHD: Coronary heart disease.

Table 2 Neurotransmitter levels of participates by quartiles of hemoglobin A1c

Neurotransmitters	HbA1c quartiles				P value
Neurotransmitters	Q1 (< 7.875), n = 32	Q2 (7.875-9.050), n = 33	Q3 (9.050-11.200), n = 32	Q4 (≥ 11.200), n = 33	P value
NAA/Cr (left hippocampus)	1.43 (0.55, 2.58)	0.74 (0.36, 1.72)	1.02 (0.80, 1.99)	1.60 (0.78, 3.10)	0.082
Cho/Cr (left hippocampus)	0.75 (0.42, 1.32)	0.96 (0.51, 1.63)	1.10 (0.29, 2.28)	1.36 (0.68, 2.27)	0.277
NAA/Cho (left hippocampus)	1.27 (0.62, 4.48)	1.02 (0.42, 1.61)	0.83 (0.44, 2.88)	0.95 (0.47, 1.81)	0.529
NAA/Cr (left brainstem area)	0.84 (0.33, 1.58)	1.17 (0.63, 2.11)	0.92 (0.30, 1.94)	1.72 (1.04, 3.48)	0.024
Cho/Cr (left brainstem area)	1.13 (0.62, 2.04)	1.55 (0.76, 3.44)	1.54 (1.28, 2.82)	1.74 (0.70, 2.49)	0.299
NAA/Cho (left brainstem area)	0.91 (0.32, 1.64)	0.71 (0.47, 1.06)	0.69 (0.31, 1.11)	1.41 (0.82, 2.05)	0.013

HbA1c: Hemoglobin A1c; NAA: N-acetylaspartate; Cr: Creatine; Cho: Choline.

Table 3 Correlation between variables and hemoglobin A1c by Spearman correlation analysis

Variables	r	P value
Age (yr)	-0.063	0.474
Sex (male/female)	-0.082	0.351
Diabetes duration (yr)	-0.150	0.090
Height (cm)	0.113	0.201
Weight (cm)	0.057	0.518
BMI (kg/m²)	-0.046	0.605
Neck line (cm)	-0.087	0.327
Waist line (cm)	-0.091	0.303
Hip line (cm)	-0.135	0.126
WHR	0.011	0.897
SBP (mmHg)	0.028	0.753
DBP (mmHg)	0.093	0.294
mALB (g/L)	0.215	0.014
TC (mmol/L)	0.154	0.081
TG (mmol/L)	-0.036	0.686
HDL-C (mmol/L)	-0.096	0.275
LDL-C (mmol/L)	0.216	0.014
HOMA-IR	0.345	< 0.001
HOMA-β	-0.316	< 0.001
Complicated with hypertension (%)	-0.015	0.868
Complicated with CHD (%)	-0.016	0.860
NAA/Cr (left hippocampus)	0.090	0.310
Cho/Cr (left hippocampus)	0.168	0.056
NAA/Cho (left hippocampus)	-0.061	0.502
NAA/Cr (left brainstem area)	0.257	0.007
Cho/Cr (left brainstem area)	0.128	0.182
NAA/Cho (left brainstem area)	0.166	0.081

BMI: Body mass index; WHR: Waist-to-hip ratio; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; mALB: Microalbumin; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-β: Homeostasis model assessment of beta cell function; CHD: Coronary heart disease; NAA: N-acetylaspartate; Cho: Choline; Cr: Creatine.

Table 4 Independent factors related to hemoglobin A1c by ordinal logistic regression analysis

Factors	OR (95%CI)	P value
mALB (g/L)	1.000 (0.999-1.001)	0.896
LDL-C (mmol/L)	1.627 (1.119-2.370)	0.011
HOMA-IR	1.107 (1.031-1.188)	0.005
HOMA-β	1.000 (1.000-1.001)	0.675
NAA/Cr (left hippocampus)	0.998 (0.971-1.025)	0.907
Cho/Cr (left hippocampus)	0.997 (0.882-1.127)	0.963
NAA/Cho (left hippocampus)	0.907 (0.795-1.035)	0.145
NAA/Cr (left brainstem area)	1.006 (0.894-1.133)	0.915
Cho/Cr (left brainstem area)	1.000 (0.901-1.108)	0.997
NAA/Cho (left brainstem area)	1.608 (1.004-2.578)	0.048

95%CI: 95% confidence interval; OR: Odds ratio; mALB: Microalbumin; LDL-C: Low-density lipoprotein cholesterol; HOMA-IR: Homeostasis model assessment of insulin resistance; HOMA-β: Homeostasis model assessment of beta cell function; NAA: N-acetylaspartate; Cho: Choline; Cr: Creatine.

Citation: Gao XY, Zhou CX, Li HM, Cheng M, Chen D, Li ZY, Feng B, Song J. Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes. World J Diabetes 2024; 15(6): 1263-1271
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1263.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1263